Riskpilot← Back to searchSign inGet full accessEmiru AB
ABActiveOrg 5590089917Gulsparvsgatan 37General medical practice activities · NACE 8621Est. 20150 employees
Revenue 2024
SEK 1,4M
-28% vs 2023
EBITDA margin
18.5%
-43% vs 2023
Equity ratio
37.6%
Financial strength
Net profit 2024
SEK 144K
-61% vs 2023
| Revenue | SEK 1,4M | -28% |
| EBITDA | SEK 264K | -43% |
| Net profit | SEK 144K | -61% |
| Total assets | SEK 564K | -50% |
| Equity | SEK 212K | -61% |
| Employees | 0 | — |
Legal name
Emiru AB
Org number
5590089917
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
27 mars 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva konsultverksamhet inom hälso- och sjukvård, äga och förvalta aktier, lös och fast egendom samt idka därmed förenlig verksamhet.
Address
Gulsparvsgatan 37
Email
emil.rucinski@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 632 | 2 394 | 1 838 | 1 986 | 1 425 |
| Staff expenses | — | — | −956 | −1 193 | −862 |
| EBITDA | 280 | 695 | 488 | 463 | 264 |
| Depreciation & amort. | −0 | −0 | — | — | −4 |
| EBIT | 280 | 695 | 488 | 463 | 260 |
| Net financials | — | — | 0 | −1 | 0 |
| Profit before tax | 280 | 695 | 488 | 462 | 189 |
| Tax | −62 | −140 | −106 | −97 | −45 |
| Net profit | 218 | 555 | 381 | 365 | 144 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 481 | 1 075 | 1 074 | 1 124 | 564 |
| Equity | 270 | 605 | 554 | 548 | 212 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 212 | 470 | 519 | 576 | 281 |
| Total debt | 212 | 470 | 519 | 576 | 281 |
EBITDA margin
18.5%
This company
15.8%
Market median
+17% vs market
20202024
Equity ratio
37.6%
This company
38.2%
Market median
+2% vs market
20202024
Return on equity
67.8%
This company
18.4%
Market median
+268% vs market
20202024
Net profit margin
10.1%
This company
8.1%
Market median
+25% vs market
20202024
Asset turnover
2.52×
This company
1.12×
Market median
+125% vs market
20202024
Debt / equity
1.66×
This company
0.62×
Market median
-168% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Emiru AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emil Stefan Rucinski | Board of Directors | 0 companies |
| Anna Jenny Sofia Hagman | Deputy Board Member | 0 companies |